Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q1 2026 · 10-Q
Revenue$17.34M$17.34M−8.3% vs Q1 2025 Net Income-$1.61M-$1.61MN/M vs Q1 2025 EPS Diluted-$0.04-$0.04N/M vs Q1 2025 Gross Profit$2,897,000−4.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flow-$167,000N/M Free Cash Flowderived-$592,000N/M Margins · derivedGross margin16.7%+0.6 pt vs Q1 2025
Operating margin-8.5%−1.3 pt vs Q1 2025
Net margin-9.3%−1.2 pt vs Q1 2025
ended Mar 31, 2026 · filed May 7, 2026 · 37 d after period end